RECRUITING

Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

Talk to us

Conditions

Cardiac Transplant DisorderHeart transplantglobal gene expressionmolecular diagnostics

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.

Official Title

Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation, a Multicenter Study (INTERHEART)

Quick Facts

Study Start:2016-01
Study Completion:2026-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02670408

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * biopsy for clinical indications
  1. * no consent
  2. * pregnant women

Contacts and Locations

Study Contact

Konrad S Famulski, PhD
CONTACT
1 7804921725
konrad@ualberta.ca
Robert Polakowski, PhD
CONTACT
1780 492 5091
polakows@ualberta.ca

Principal Investigator

Philip F Halloran, MD PhD
PRINCIPAL_INVESTIGATOR
University of Alberta

Study Locations (Sites)

UCLA Medical Centre
Los Angeles, California, 90024
United States
Cedars-Sinai Heart Institute
Los Angeles, California, 90048
United States
Annette C. and Harold C. Simmons Transplant Institute, BaylorScott&White Research Institute
Dallas, Texas, 75246
United States
Cardiovascular Medicine, University of Utah Health
Salt Lake City, Utah, 84132
United States
Virginia Commonwealth University, Division of Cardiology
Richmond, Virginia, 23298
United States

Collaborators and Investigators

Sponsor: University of Alberta

  • Philip F Halloran, MD PhD, PRINCIPAL_INVESTIGATOR, University of Alberta

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-01
Study Completion Date2026-07

Study Record Updates

Study Start Date2016-01
Study Completion Date2026-07

Terms related to this study

Keywords Provided by Researchers

  • Heart transplant
  • global gene expression
  • molecular diagnostics

Additional Relevant MeSH Terms

  • Cardiac Transplant Disorder